Navellier & Associates Inc Eton Pharmaceuticals, Inc. Transaction History
Navellier & Associates Inc
- $915 Million
- Q3 2025
A detailed history of Navellier & Associates Inc transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Navellier & Associates Inc holds 17,494 shares of ETON stock, worth $308,944. This represents 0.04% of its overall portfolio holdings.
Number of Shares
17,494Holding current value
$308,944% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ETON
# of Institutions
97Shares Held
15MCall Options Held
242KPut Options Held
11.8K-
Opaleye Management Inc. Boston, MA2.86MShares$50.5 Million9.75% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$35.9 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.34MShares$23.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$20.8 Million0.73% of portfolio
-
Geode Capital Management, LLC Boston, MA574KShares$10.1 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $447M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...